title: Device deals dominate. DJO, Biomet buyouts gain steam as Abbott's fizzles.
authors.forename: Shawn
authors.initials: S
authors.lastname: Rhea
mesh_terms: D004864:Equipment and Supplies / Q000191:economics*; D019981:Health Care Sector / Q000639:trends*; D006801:Humans; D007449:Investments / Q000639:trends*; D009983:Orthopedic Equipment / Q000191:economics; D019095:Point-of-Care Systems / Q000191:economics; D014481:United States